Gilder Gagnon Howe & Co’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-18,842
| Closed | -$199K | – | 266 |
|
2022
Q4 | $199K | Buy |
+18,842
| New | +$199K | ﹤0.01% | 238 |
|
2021
Q3 | – | Sell |
-288,070
| Closed | -$2.43M | – | 446 |
|
2021
Q2 | $2.43M | Sell |
288,070
-2,821,804
| -91% | -$23.8M | 0.01% | 297 |
|
2021
Q1 | $32.6M | Buy |
3,109,874
+750,192
| +32% | +$7.87M | 0.18% | 124 |
|
2020
Q4 | $40M | Buy |
2,359,682
+208,280
| +10% | +$3.53M | 0.2% | 117 |
|
2020
Q3 | $27.6M | Buy |
2,151,402
+900,142
| +72% | +$11.5M | 0.17% | 120 |
|
2020
Q2 | $17.7M | Buy |
+1,251,260
| New | +$17.7M | 0.14% | 123 |
|